CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Achillion's hepatitis C drug cures all patients in mid-stage trial
08-15-2014
Rifamycin-containing regimens may be preferable in latent tuberculosis
08-14-2014
Vertex to end sales of hepatitis C drug telaprevir (Incivek)
08-13-2014
Intercept drug for non-alcoholic steatohepatitis found effective
08-12-2014
View Complete News Library
 
 
September 5-6
GALA (GI and Liver Association of the Americas) Conference
Montreal, Canada
September 19-20
GALA (GI and Liver Association of the Americas) Conference
San Francisco, California
October 17-22, 2014
American College of Gastroenterology (ACG)
Philadelphia, PA
November 7-11
The Liver Meeting 2014
Boston, MA
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
New Therapies for Hepatitis C: Considerations in Patients with Renal Impairment
 
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)
 
Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response
 
Delivery of treatment for hepatitis C virus infection in the primary care setting
 
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
 
Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection
 
 
A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity
 
Re-appraisal of old and new diagnostic tools in the current management of chronic hepatitis B
 
Understanding early serum hepatitis D virus and HBsAg kinetics during pegylated interferon-alfa therapy via mathematical modeling
 
A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4, and 12 Months of Age
 
Validation of EncephalApp, Smartphone-based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
 
Hepatic encephalopathy: how to test and treat
 
 
Brain magnetic resonance in hepatic encephalopathy
 
Sodium benzoate for treatment of hepatic encephalopathy
 
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
 
Systematic Review and Meta-Analysis of Adjuvant I131 Lipiodol after Excision of Hepatocellular Carcinoma
 
Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
 
Adjuvant Intraarterial Lipiodol or 131I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.